Anticorps Polyclonal de lapin anti-LYPD6B

LYPD6B Polyclonal Antibody for IHC, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris

Applications

IHC, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 25508-1-PBS

Synonymes

CT116, Ly6/PLAUR domain-containing protein 6B, LYPD7



Informations sur le produit

25508-1-PBS cible LYPD6B dans les applications de IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain, souris

Réactivité Humain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène LYPD6B Protéine recombinante Ag22008
Nom complet LY6/PLAUR domain containing 6B
Masse moléculaire calculée 183 aa, 20 kDa
Numéro d’acquisition GenBankBC040176
Symbole du gène LYPD6B
Identification du gène (NCBI) 130576
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

LYPD6B (containing the Ly6/PLAUR domain protein 6B), also known as LYPD7, is a member of the Ly6/uPAR superfamily of proteins. These proteins typically exhibit membrane-anchoring properties and participate in critical cellular signaling and adhesion processes. It is predominantly expressed in the central nervous system. LYPD6B functions as a key regulatory subunit that interacts with and modulates nicotinic acetylcholine receptors (nAChRs), specifically influencing their maturation, stability, and functional properties at synapses. This interaction is crucial for normal cholinergic signaling, which underpins cognitive functions such as learning and memory. Dysfunction of the LYPD6B is associated with multiple neurological disorders. (PMID: 23186997, PMID: 34631692, PMID: 39433742)

{{ptg:RelatedPrimaryAntibodies}}